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Abstract
Dicer ribonucleases of plants and invertebrate animals including Caenorhabditis elegans recognize and process a viral RNA
trigger into virus-derived small interfering RNAs (siRNAs) to guide specific viral immunity by Argonaute-dependent RNA
interference (RNAi). C. elegans also encodes three Dicer-related helicase (drh) genes closely related to the RIG-I-like RNA
helicase receptors which initiate broad-spectrum innate immunity against RNA viruses in mammals. Here we developed a
transgenic C. elegans strain that expressed intense green fluorescence from a chromosomally integrated flock house virus
replicon only after knockdown or knockout of a gene required for antiviral RNAi. Use of the reporter nematode strain in a
feeding RNAi screen identified drh-1 as an essential component of the antiviral RNAi pathway. However, RNAi induced by
either exogenous dsRNA or the viral replicon was enhanced in drh-2 mutant nematodes, whereas exogenous RNAi was
essentially unaltered in drh-1 mutant nematodes, indicating that exogenous and antiviral RNAi pathways are genetically
distinct. Genetic epistatic analysis shows that drh-1 acts downstream of virus sensing and viral siRNA biogenesis to mediate
specific antiviral RNAi. Notably, we found that two members of the substantially expanded subfamily of Argonautes specific
to C. elegans control parallel antiviral RNAi pathways. These findings demonstrate both conserved and unique strategies of
C. elegans in antiviral defense.
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Introduction
Innate immunity is active immediately upon pathogen attack
and represents an ancient defense mechanism conserved in diverse
multicellular organisms. Innate immunity is initiated by pattern
recognition receptors (PRRs) that recognize conserved molecular
patterns associated with microbes. Well-characterized PRR
families include the transmembrane Toll-like receptors (TLRs)
and the cytosolic NOD-like receptors (NLRs) and RIG-I-like RNA
helicase receptors (RLRs), all of which contain members in
vertebrates that recognize viral single- and/or double-stranded
RNAs as the pathogen signatures [1–3]. Recognition of pathogens
by PRRs typically triggers protein-protein interactions of PRRs
with downstream signaling factors leading to the nucleus
translocation of a transcriptional factor such as NF-kB and the
subsequent transcription of immunity effector genes. The Dicer
family of ribonucleases also recognizes viral RNA like these PRRs
to initiate the viral immunity in plants and invertebrates that is
mechanistically related to RNA silencing or RNA interference
(RNAi). Unlike TLR and RLRs, however, Dicer further processes
the viral RNA trigger into small RNAs of 21–24 nucleotides to
guide specific antiviral silencing [4].
In addition to two type III RNase domains and a dsRNA-
binding domain (dsRBD), Dicer contains an RNA binding domain
called PAZ and an N-terminal RNA helicase domain that is closely
related to RLRs [5,6]. The Dicer family proteins produce small
interfering RNAs (siRNAs) and microRNAs (miRNAs) in many
eukaryotes, which are loaded in an Argonaute (AGO)-containing
effector complex to silence gene expression by RNA cleavage,
translational arrest, or methylation of DNA and chromatin. In
fungi, plants and Caenorhabditis elegans, siRNAs are further amplified
in a process that depends on de novo synthesis of dsRNA by
cellular RNA-dependent RNA polymerase (RDR).
Genetic requirements of the Dicer-initiated viral immunity have
been characterized more extensively in Arabidopsis thaliana and
Drosophila melanogaster using known mutants in various RNA
silencing pathways [7]. The prevailing model for antiviral silencing
against RNA viruses is that it acts via the canonical dsRNA-siRNA
pathway of RNAi. This is supported by the detection of virus-
derived siRNAs (viRNAs) of two polarities covering the entire
length of viral genomic RNAs in the infected cells and the
identification of the siRNA-producing Dicers in the biogenesis of
viRNAs in both D. melanogaster and A. thaliana [4,8–14]. Almost all
of the genes known to participate in A. thaliana antiviral silencing
have been implicated in the RDR-dependent synthesis of dsRNA
in transgene-induced RNA silencing [4,15–20]. In D. melanogaster,
antiviral silencing induced by distinct positive-strand RNA viruses
including Flock house virus (FHV), requires the same set of the
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dispensable for the biogenesis and function of miRNAs
[13,14,21,22]. A recent study found that viral dsRNA produced
during initiation of FHV progeny RNA synthesis is recognized by
Dicer-2 (DCR-2) and diced into viRNAs to trigger antiviral
silencing [23]. Infection of mammalian cells with some DNA
viruses induces production of virus-derived miRNAs capable of
silencing the antisense mRNAs of the cognate viruses [24].
However, there is currently no evidence for the production of viral
siRNA in mammals in response to RNA viruses, suggesting that
RNA viruses are sensed by unrelated PRRs in invertebrates and
vertebrates [4].
C. elegans is an excellent model system for studying many aspects
of biology, including host responses to bacterial pathogens [25,26].
C. elegans lacks NLRs and NF-kB-like transcriptional factors but
encodes a single TLR. C. elegans also encodes a family of Dicer-
related helicases (DRH), DRH-1, DRH-2 and DRH-3, which are
highly homologous to the DExD/H box RNA helicase domain
found in Dicer and the mammalian RLR family composed of
RIG-I, MDA5 and LGP2 [6,27,28]. The RNA silencing
machinery of C. elegans is characterized by a single Dicer (dcr-1),
4 RDRs (eg, ego-1 and rrf1–rrf-3) and 27 AGOs [29,30]. Both
miRNAs and siRNAs are produced by DCR-1 whereas PIWI-
interacting RNAs (piRNAs, also known 21U RNAs) is Dicer-
independent. Processing both endogenous (endo) and exogenous
(exo) dsRNA into siRNAs further requires the dsRNA-binding
protein RDE-4 although distinct AGO and RDR proteins
participate in endo and exo siRNA pathways [6,31–35]. The C.
elegans family of AGOs, the largest of any organisms examined to
date, is divided into three subfamilies. The AGO and PIWI
subfamilies are required for the biogenesis of miRNAs and
piRNAs, respectively, but ergo-1 in the PIWI subfamily has an
essential role in the production of endo-siRNAs [31,36–38]. The
third subfamily is worm-specific and contains 18 members, many
of which such as rde-1, ppw-1, C04F12.1, sago-1, and csr-1, act in
parallel or sequentially to mediate the exo-siRNA pathway [39–
42]. The exo-siRNA pathway requires amplification by rrf-1 in the
soma and ego-1 in the germline whereas rrf-3 is essential for the
biogenesis of endo-siRNAs [34,43]. Interestingly, exo-RNAi is
enhanced in worm mutants defective for several components of the
endo-siRNA pathway including eri-1, ergo-1 and rrf-3, suggesting
antagonism between the two siRNA pathways
[27,30,34,41,44,45].
A natural virus for C. elegans is not known. However, cultured
primary cells and living animals of C. elegans can be infected
respectively by Vesicular stomatitis virus (VSV) and Vaccinia virus
and living animals support complete replication of the FHV RNA
genome engineered to be transcribed from an integrated transgene
[46–49]. Infection of VSV, which contains a negative-strand RNA
genome, is associated with the production of VSV-specific small
RNAs and is potentiated in both nematode cells derived from
exoRNAi-defective C. elegans mutants (rde-1; rde-3, rde-4, and rrf-1)
and wild-type cells depleted of either DCR-1 or C04F12.1, but is
inhibited in rrf-3 and eri-1 mutants that exhibit an enhanced
exoRNAi response [47,48]. The positive-strand genome of FHV is
divided into two RNAs. RNA1 (3.1 kb) encode the viral RNA-
dependent RNA polymerase (RdRP) and can self-replicate
independently of RNA2 (1.4 kb), which encodes the capsid
protein. Although FHV is a natural insect virus, it replicates
efficiently on outer mitochondria membranes of diverse eukaryotic
cells, indicating conserved mitochondria targeting of the viral
replication complex [50–52]. FHV RNA3 (387 nt) is a product of
RNA1 replication and acts as mRNA of the B2 protein, a viral
suppressor of RNAi (VSR) essential for FHV infection in D.
melanogaster [13,14,21,53]. We showed that replication of a B2-
deficient FHV mutant occurred robustly in the rde-1 mutant
nematodes but was severely inhibited in wild-type nematodes,
indicating restriction of FHV replication by the exo-RNAi
pathway in C. elegans [46]. These studies together strongly indicate
that C. elegans encodes an active antiviral RNAi pathway that is
induced by either direct viral infection [47,48] or replication of a
viral RNA genome initiated intracellularly [46], the latter of which
bypasses the initial steps such as cell entry that occur in viral
infection of natural hosts.
Here we describe development of a transgenic C. elegans strain
for the genetic characterization of the antiviral RNAi pathway.
Use of the reporter strain in a feeding RNAi screen led to the
identification of a largest set of putative genes in antiviral RNAi
pathway in any organism. In particular, we showed that drh-1 and
drh-2 of the three nematode drh genes participated in the regulation
of antiviral RNAi. An extensive genetic analysis indicated that
unlike mammalian RLRs, C. elegans drh-1 acts downstream of virus
sensing and viRNA biogenesis and that exogenous and antiviral
RNAi pathways have distinct genetic requirements. Both the
conserved and unique strategies of C. elegans in antiviral defense are
discussed.
Results
Identification of genes required for antiviral silencing in
C. elegans by feeding RNAi
We have previously described a derivative of the infectious full-
length cDNA clone of FHV RNA1, pFR1gfp [53], in which eGFP
coding sequence replaces most of the VSR B2 coding sequence
(Figure 1A). The inserted eGFP fused with the N-terminal 23
codons of B2, is expressed only from the recombinant RNA3
produced during replication of FR1gfp, but not directly from
FR1gfp because its initiation codon is more than 2.7 kb away from
the 59-terminus of FR1gfp RNA (Figure 1A). FR1gfp is defective
in RNAi suppression due to loss of B2 expression but not in
replication so that productive FR1gfp replication and expression of
eGFP from the FHV replicon occur only after antiviral RNAi is
suppressed by either co-expression of B2 or genetic disruption of
Author Summary
The genome of Caenorhabditis elegans encodes three
Dicer-related helicases (DRHs) highly homologous to the
DExD/H box helicase domain found in two distinct families
of virus sensors, Dicer ribonucleases and RIG-I-like helicas-
es (RLRs). Dicer initiates the specific, RNAi-mediated viral
immunity in plants, fungi and invertebrates by producing
virus-derived small interfering RNAs (siRNAs). By contrast,
mammalian RLRs trigger interferon production and broad-
spectrum viral immunity, although one of the three RLRs
may act as both a negative and positive regulator of viral
immunity. In this study we developed a transgenic C.
elegans strain for high-throughput genetic screens and
identified 35 genes including drh-1 that are required for
RNAi-mediated viral immunity. Genetic epistatic analyses
demonstrate that drh-1 mediates RNAi immunity down-
stream of the production of viral siRNAs. Notably, we
found that drh-2 functions as a negative regulator of the
viral immunity. Thus, both nematode DRHs and mamma-
lian RLRs participate in antiviral immune responses. Unlike
mammalian RLRs, however, nematode DRH-1 employs an
RNAi effector mechanism and is unlikely to be involved in
direct virus sensing.
Genetic Analysis of Antiviral RNAi in C. elegans
PLoS Pathogens | www.plospathogens.org 2 February 2009 | Volume 5 | Issue 2 | e1000286the antiviral RNAi pathway in cultured fruit fly and mosquito cells
[53]. To develop a model suitable for genetic screens to identify
new components in antiviral RNAi, we generated C. elegans strains
carrying a chromosomally integrated transgene that codes for
FR1gfp under the control of a heat-inducible promoter.
We found that no green fluorescence or only a tiny green spot in
the pharynx area was observed in FR1gfp worms after heat
induction of the FHV replicon transgene (Figure 1B, top left). In
contrast, bright green fluorescence was detected throughout the
animal body after FR1gfp worms were fed on the E. coli food that
expresses rde-1 dsRNA, which depletes mRNA of rde-1 in a process
referred as feeding RNAi (Figure 1B, top middle). Abundant
expression of eGFP was also observed in FR1gfp worms after a
loss-of-function rde-1 allele was introduced into FR1gfp worms by
genetic crosses (data not shown). Northern blot hybridizations
confirmed the abundant accumulation of the chimeric RNA1 and
RNA3 in FR1gfp worms after rde-1 depletion, but FR1gfp
replication was inhibited in FR1gfp worms without rde-1 depletion
(Figure 1C, compare lanes 1/2 and 4/5). Productive replication of
FR1gfp replicon was similarly rescued by the loss-of-function rde-1
allele in the second FR1gfp worm strain in which the FR1gfp
transgene was integrated at a different chromosomal location
(Figure 2B, and data not shown). Thus, as found previously in
cultured fruit fly and mosquito cells [53], productive FR1gfp
replication and detection of extensive eGFP expression in FR1gfp
worms depend on the genetic disruption of the antiviral RNAi
pathway, suggesting that FR1gfp worms could be screened for new
components of the pathway by feeding RNAi.
To test this idea, we searched for antiviral RNAi factors among
genes shown previously to play a role in exo-RNAi [30,54]. The
Figure 1. Screening for viral immunity genes in C. elegans by feeding RNAi. (A) Genome structure and expression of wildtype FHV RNA1
(FR1) and its B2-deficient mutant, FR1gfp, that expresses the enhanced GFP in place of B2. (B) Detection of green fluorescence in FR1gfp reporter
worms after feeding RNAi targeting specific genes or the commonly used L4440 vector as indicated, photographed 48 hours after induction of the
replicon replication. (C) Accumulation of FR1gfp genomic (RNA1) and subgenomic RNA (RNA3) by northern blotting in FR1gf worms with (lanes 3–12)
and without (lanes 1–2) feeding RNAi of specific worm genes. Two independent tests were analyzed for each E. coli strain. Methylene blue staining of
total RNA was provided to show equal loading.
doi:10.1371/journal.ppat.1000286.g001
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PLoS Pathogens | www.plospathogens.org 3 February 2009 | Volume 5 | Issue 2 | e1000286Figure 2. Molecular and functional characterization of the drh-1 and drh-2 genes. (A) Accumulation of the FR1gfp replicon RNAs in genetic
mutant worm strains carrying the same FR1gfp transgene array. Total RNA was also analyzed from wildtype N2 worms with (N2) and without the
FR1gfp transgene (N2*) 48 hours after induction of the replicon replication (h.a.i.). (B) Induction of the RNAi immunity by the replicon in a worm
integrant different from that analyzed in (A). (C) Molecular structures and genetic lesions of the drh-1 and drh-2 genes. (D) Accumulation of (-) viral
siRNAs in single knockout worm mutants 48 hours after induction of the replicon replication. 45 mg of total small RNAs was loaded in each lane. A
combination of 18
32P end-labeled DNA oligos corresponding to eGFP coding sequence in tandem was used as the probe for viral siRNA detection.
The same filters were probed for miR-58 after stripping as the loading control. (E) Detection of drh-1 and drh-2 transcripts before and after induction
of the replicon replication. Two independent tests were analyzed for each strain. (F) Time course analysis of the accumulation of the replicon RNAs in
wildtype and mutant worms 2, 6, and 16 h.a.i. Total RNA extracted from FR1gfp rde-1 worms 48 h.a.i. was loaded as a control (lane rde-1*). Methylene
blue staining of total RNA was provided to show equal loading.
doi:10.1371/journal.ppat.1000286.g002
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dcr-1, rde-1, and rde-4, which, together with rrf-1 and C04F12.1,
were shown previously to be required for antiviral RNAi against
VSV and for exo-RNAi [30,41,47,48]. A specific role of these
genes in worm antiviral RNAi was verified by demonstrating
genetic rescue of the B2-deficient FHV replicon in FR1gfp worms
following introduction of genetic loss-of-function mutations in rde-
1, rde-4, rrf-1 or C04F12.1 by genetic crosses (Figure 2A). These
results showed that the B2-deficient FHV replicon transcribed
from a nuclear transgene was silenced in FR1gfp worms by the
same set of genes known to participate in worm antiviral immunity
against VSV infection. Thus, the FR1gfp worm strain provided an
alternative model to the VSV infection system for the genetic
characterization of the RNAi-mediated antiviral immunity in C.
elegans, including the use of FR1gfp worms for feeding RNAi
screens.
In addition to dcr-1, rde-1, and rde-4, 32 of 98 candidate genes
tested were required for silencing the viral replicon in C. elegans in
three independent feeding RNAi screens (Figure 1B/1C, Table
S1). Our result suggests that most of the RNAi factors identified
from previous genetic and feeding RNAi screens, including mut-7
and mut-16 [55], may not contribute to antiviral RNAi.
Nevertheless, our screen provided the largest set of putative
antiviral RNAi factors in any organism (Table S1), which include
rsd-2 (Figure 1B/1C), required for systemic RNAi [56], and drh-1.
We focused on drh-1 identified from the feeding RNAi screen and
its related gene drh-2 because of their homology to the mammalian
RLR family of cytosolic sensors for RNA viruses [2,6,27].
drh-1 is essential for worm antiviral RNAi that is
negatively regulated by drh-2
drh-1 encodes one of the three closely related worm members of
the RLR family [6,27]. To verify the result from feeding RNAi, we
identified presumptive null alleles of drh-1(tm1329) and drh-
2(ok951) and introduced them respectively into FR1gfp worms by
genetic crosses (Figure 2C). We did not examine drh-3 in this study
because drh-3(tm1217) mutant worms are sterile [27]. We found
that drh-1 mutant worms exhibited no visible morphological and
developmental phenotypes. However, drh-2 worms were notice-
ably smaller than wildtype worms at the same developmental
stages and were late by ,8 hours in laying eggs (data not shown),
suggesting that drh-2 may have a role in development. Northern
blot hybridizations detected mRNAs specific to drh-1 and drh-2 in
wildtype worms and deletion of 483- and 789-nucleotide genomic
DNA respectively in drh-1 and drh-2 mutants caused visible shifts of
the corresponding mRNAs (Figure 2E). However, neither was
transcriptionally induced 48 hours after the initiation of FR1gfp
replication or earlier (Figure 2E and data not shown).
We found that RNAs 1 and 3 of the B2-deficient FHV replicon
accumulated to high levels in drh-1 mutant worms as compared to
wild-type N2 worms (Figure 2A, compare lanes 3/4 and 9/10).
Thus, an essential role for drh-1 in antiviral silencing revealed by
feeding RNAi experiments was confirmed by an independent
approach. By comparison, the accumulation levels of the replicon
RNAs 1 and 3 were similar in drh-1, rde-1 and rde-4 worms, but were
higher in these worms than in rrf-1 and C04F12.1 mutant worms in
at least five independent experiments (Figure 2A). These results
indicate that antiviral silencing against the FHV replicon was
inhibited in drh-1 worms as effectively as in rde-1 and rde-4 mutants,
andmoreeffectivelythaninrrf-1andC04F12.1mutants(Figure2A).
In contrast, the FHV replicon was not rescued in drh-2 mutants
(Figure 2A, lanes 11–12). Although longer exposure revealed low
accumulation levels of the FHV replicon in wild-type worms, the
accumulation of the FHV replicon was either undetectable or
lower in drh-2 mutants than in wildtype worms (Figure 2A,
compare lanes 17/18 and 21/22). Apparently this effect is not
transgenic allele specific in that the same effect was also observed
for another FR1gfp transgenic allele (Figure 2B, compare lane 28
and lane 25). As expected, fosmid WRW0640F2, which contains
both drh-1 and drh-2 wild-type alleles, was able to rescue drh-1 and
drh-2 function in the corresponding mutants when assayed for
FR1gfp replication (data not shown). These results show that drh-1
is as important as rde-1 and rde-4 in the worm antiviral RNAi
against FHV, whereas drh-2 may negatively regulate this
immunity. Similarly reduced accumulation of the FHV replicon
was also observed in worms defective for ergo-1 (Figure 2A, lanes
23 and 24), which encodes an AGO that is required for the
biogenesis of endo-siRNAs but is antagonistic to exo-RNAi [41].
Several lines of evidence indicate that drh-2 and ergo-1 act as
negative regulators of antiviral RNAi rather than positive
regulators of FHV replication. FR1gfp is defective in RNAi
suppression but not in replication in fly and mosquito cells [53]
and in worms because FR1gfp replicated to high levels in several
single mutants including rde-4 (Figure 2A) and robust replication of
FR1gfp was not inhibited by the drh-2 and ergo-1 alleles in rde-4;drh-
2 (see the last section of Results below) and rde-4;ergo-1 (data not
shown) double mutants. In addition, both drh-2 and ergo-1
negatively regulate exogenous RNAi (Figure 3, see below).
We further performed time course analysis of the accumulation
of the FHV replicon in wild-type and seven worm mutants 2, 6
and 16 hours after transcriptional induction of FR1gfp (Figure 2F).
Primary transcripts of FR1gfp initially accumulated to comparable
levels in wild-type and all of the seven mutant worm strains
examined at two hours after heat induction, indicating that none
of these mutant alleles had a major effect on the transcription of
the FR1gfp locus [30]. Six hours after induction, FHV RNA1 and
its replication product RNA3 were detectable in rde-1, rde-4 and
drh-1 mutants, but not in wild-type, rrf-1, C04F12.1, drh-2,o rergo-1
mutants. At 16 hours after induction, productive replication of the
viral replicon also became visible in rrf-1 worms but not in
C04F12.1, drh-2,o rergo-1 worms (Figure 2F). These data indicate
that the viral RNA clearance was triggered by viral RNA
replication in an RNAi-dependent process that might require
early and simultaneous participation of DRH-1, RDE-1 and
RDE-4.
Characterization of drh-1 and drh-2 mutants in response
to exo-RNAi
DRH-1 was first identified as an interacting protein of DCR-1
and subsequent affinity purification coupled with mass spectrom-
etry implicates all three DRH proteins as DCR-1 interactors
[6,27]. drh-3 mutant worms were defective in germline RNAi but
were wild-type in somatic RNAi; however, both germline and
somatic RNAi was dramatically reduced in worms treated with
either drh-1 or drh-2 (or both) dsRNAs [6,27,54,57]. While these
data indicate that drh-3 is essential for germline RNAi, it was
uncertain if a specific member of the DRH family plays an
essential role in somatic RNAi since depletion of the homologous
drh genes by dsRNA lacks specificity.
We found that drh-1 mutant worms, either with or without the
FR1gfp transgene, remained as sensitive as wild-type worms to
feeding RNAi targeting either the maternally expressed skn-1 (data
not shown) or dpy-13 (Figure 3C), and to microinjection of dsRNA
targeting muscle specific gene unc-22, which produces both the
light (twitching) and severe (paralysis) knockdown phenotypes
(Figure 3A/3B). Thus, drh-1 is dispensable for somatic RNAi,
which is in contrast to its essential role in antiviral silencing.
Nevertheless, we found a slightly lower percentage of the injected
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(Figure 3A/3B), and the difference detected was statistically
significant (P,0.05), illustrating that drh-1 worms exhibited a weak
deficiency in somatic RNAi. These results suggest that DRH-1
may be more efficient to mediate RNAi in the soma of wild-type
worms, but this function of DRH-1 is genetically redundant and
could be substituted for by another DRH member in drh-1 mutant
worms.
Surprisingly, drh-2 mutant worms exhibited enhanced sensitivity
to the injection RNAi targeting unc-22 as compared to wild-type
worms and the difference was more obvious when low concen-
tration of dsRNA was injected (Figure 3A/3B). Feeding RNAi
targeting dpy-13 led to mild dumpy phenotype in wild-type and
drh-1 worms, but drh-2 worms displayed severe dumpy phenotype
as did worm mutants known to exhibit an enhanced RNAi
phenotype such as ergo-1 (Figure 3C) and eri-1 [45,47,48]. In
contrast to wildtype and drh-1 worms, rde-1 worms were resistant to
dpy-13 RNAi as expected (Figure 3C). These results indicate that
somatic RNAi is partially suppressed by drh-2 in wild-type worms,
which is similar to its inhibitory role in antiviral RNAi.
drh-1 and drh-2 are dispensable for the biogenesis of
miRNAs, endo-siRNAs and piRNAs
drh-3 is required for the biogenesis of endo-siRNAs, but not for
miRNAs or piRNAs [27,57]. Production of endo-siRNAs is also
dependent on ergo-1, which inhibits both somatic RNAi and
antiviral silencing. To investigate the mechanism of drh-1 and drh-
2, we further determined if either was involved in the biogenesis of
the three classes of C. elegans small RNAs. We found that neither
drh-1 nor drh-2 was required for the biogenesis of miRNAs
(Figure 4A, lanes 5 and 6), which is also known to be independent
of rde-4. Minor changes in the accumulation of miRNAs observed
occasionally in drh-1 mutant worms were not reproducible
(Figure 2D/3A/3B/5B). The rde-4-dependent endo-siRNAs
K02E2.6 and X-cluster siRNAs also accumulated to wild-type
levels in both drh-1 and drh-2 mutants (Figure 4A/4B). The
recently characterized piRNAs also accumulated to wild-type
levels in both drh-1 and drh-2 mutants as in rde-4, rde-1, rrf-1, ppw-2
and ergo-1 mutants (Figure 4B). Thus, drh-1 and drh-2 do not
appear to contribute to the biogenesis of any of the known
endogenous small RNAs in C. elegans, suggesting that drh-2
negatively regulates somatic RNAi and antiviral silencing in a
mechanism distinct from ergo-1.
drh-1 acts downstream of rde-4-dependent production of
viRNAs
An antiviral RNAi component may function in virus sensing,
the biogenesis or the antiviral activity of viRNAs [4]. FHV-specific
viRNAs of the antigenomic polarity, (-)viRNAs, were detectable in
both drh-1 and rde-1 mutants (Figure 2D, lanes 2 and 4). Probing
for viRNAs of the genomic polarity resulted in a smear and no
discrete bands were detected in any of the worm strains tested
either before or after transcriptional induction of FR1gfp (data not
shown). FHV viRNAs accumulated to much lower levels in worms
than in fruit flies [13,23]. ViRNAs in worm cells infected with
VSV were only detected by the RNase protection assay [47],
which is far more sensitive than Northern blot hybridization [58].
We found that (-)viRNAs were undetectable in wild-type, drh-2 or
ergo-1 mutant worms (Figure 2D, lanes 1 and 5; Figure 5B, lane 8),
which is likely due to the inhibition of the viral replication
(Figure 2A, lanes 3/4, 11/12, 23/24) and consequently lower
levels of viral dsRNA for dicing in these worms. The FHV replicon
replicated to similarly high levels in rde-1, rde-4 and drh-1 mutant
worms (Figure 2A), but viRNAs were not detectable in rde-4
worms, unlike in rde-1 and drh-1 worms (Figure 2E). These results
therefore show that RDE-4 is essential for the production of FHV
viRNAs whereas either DRH-1 or RDE-1 is dispensable.
However, since viRNAs produced in drh-1 and rde-1 worms were
not able to inhibit the replication of the VSR-deficient viral
replicon (Figure 2A), we further conclude that both RDE-1 and
DRH-1 are required for the antiviral activity of viRNAs. The
observations that the viral RNA trigger was detected and
processed into viRNAs in rde-1and drh-1 mutant worms ruled
out a direct role of either gene in virus sensing.
Figure 3. drh-2 is a negative regulator of exogenous RNAi. (A
and B) unc-22 RNAi phenotype in response to unc-22 dsRNA
microinjected at 25 and 100 mg/ml, respectively. 30 to 40 worms were
used for unc-22 dsRNA injection. Shown here are the percentages of
twitching and paralyzed F1 progenies of each injected worm collected
between 8 and 32 hours post injection. The error bars indicate standard
deviation for the paralysis phenotype. (C) Morphological phenotype of
the F1 progenies of wildtype and mutant worms after feeding RNAi
targeting dpy-13. All worm strains were synchronized before feeding
RNAi.
doi:10.1371/journal.ppat.1000286.g003
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To determine the epistatic relationships among the identified
antiviral RNAi components, we constructed seven double
knockout worm mutants by genetic crosses. First, rescue of the
VSR-deficient viral replicon was stronger in rde-1 worms than in
the mutant worms defective for C04F12.1 (Figure 5C), which
encodes an AGO closely related to rde-1 in the expanded group of
AGOs specific to C. elegans. However, the viral replicon replicated
to higher levels in the rde-1:C04F12.1 double mutant than in either
single mutant (Figure 5C, compare lane 4 and lanes 2 and 3).
Thus, there is an additive effect of the two mutant alleles in
blocking antiviral RNAi, indicating parallel AGO pathways for
antiviral silencing in C. elegans. Second, the viral replicon did not
accumulate to higher levels in rde-4;drh-1 double mutant than in
either rde-4 or drh-1 single mutant (Figure 5A, compare lane 6 and
lanes 3 and 4). viRNAs were not detectable in rde-4;drh-1 worms
(Figure 5B, lane 5), which was similar to rde-4 worms but distinct to
drh-1 worms. These results illustrated that rde-4 and drh-1 act in the
same antiviral RNAi pathway and placed rde-4 in the upstream of
drh-1. Third, abundant viRNAs were detected in rde-1;drh-1 worms
as was found in rde-1 and drh-1 single mutants, further confirming
the above conclusion that neither gene is essential for viRNA
production.
Fourth, we found that the viral replicon replicated to similar
levels in rde-1, rde-4 single mutants and rde-1;drh-2 and rde-4;drh-2
double mutants (Figure 5A, compare lanes 11 and 12 with lanes 8
and 9). This result showed that the drh-2 mutant allele failed to
enhance antiviral RNAi when either rde-4 or rde-1 was not
functional, suggesting that the rde-4-initiated pathway was targeted
by drh-2 for negative regulation. Fifth, the accumulation levels of
the viral replicon were similar in the ergo-1;drh-1 double mutant
and the drh-1 single mutant (Figure 5E), indicating that the ergo-1
mutant allele also became ineffective in enhancing antiviral RNAi
when rde-4-initiated pathway was inactive. However, we found
that the ergo-1;drh-1 double mutant exhibited enhanced sensitivity
to somatic RNAi as did the ergo-1 single mutant (Figure 5D),
further demonstrating that drh-1 was dispensable for exo-RNAi.
Discussion
Recent studies demonstrate that viruses can infect, replicate,
and assemble within C. elegans cells and that RNA viruses are
targeted for silencing by the canonical RNAi pathway in C. elegans
[46–49]. These findings suggest that C. elegans could become an
important model for understanding basic aspects of virus–host
interactions [59]. In this work, we developed a C. elegans model for
the genetic analysis of antiviral RNAi that exhibits several notable
features. Our system is amenable to the powerful genetic tools in
C. elegans since initiation of viral replication is inducible without the
need for viral inoculation. The viral replication cycle in our system
begins with translation of the viral RdRP in the cytosol from
nuclear transcripts and bypasses the initial steps in virus entry
Figure 4. Analysis of endogenous small RNAs. (A) Accumulation of K02E2.6 and X-cluster siRNAs as well as miR-58, miR-238, and let-7 and lin-4
miRNAs in wildtype and mutant worm strains with (lane 1) or without the FR1gfp transgene (lanes 2–9). 45 mg of total small RNAs was loaded in each
lane. The same filter was repeatedly reprobed after stripping. Small RNAs loaded in lane 1 was extracted from FR1gfp worms 48 hours post induction.
(B) Accumulation of 21U1 piRNA in wildtype and mutant worm strains in the absence of FR1gfp transgene. End-labeled DNA oligos complementary
to endo-siRNAs, miRNA and 21U1 piRNA were used as the probes. Ethidium bromide staining of tRNAs was provided to show equal loading.
doi:10.1371/journal.ppat.1000286.g004
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all of the five C. elegans genes known to participate in antiviral
RNAi immunity against VSV infection were also required for
inhibiting the replication of the FHV replicon. In addition, mutant
alleles of genes in the endo-RNAi pathway that enhance exoRNAi
response also increased potency of antiviral RNAi against both
VSV (eri-1 and rrf-3) [47,48] and the FHV replicon (ergo-1). These
data indicate that antiviral RNAi is triggered during intracellular
viral RNA replication in the absence of receptor-mediated virus
entry across the plasma membrane as is known for viral immunity
initiated by mammalian RLRs. Furthermore, removal of VSR B2
enhances the sensitivity of the GFP-expressing FHV replicon to
antiviral RNAi. This is in contrast to the use of VSR-expressing
wild-type viruses in previous genetic analyses [16,60], which may
explain why our pilot feeding RNAi screen led to the identification
of a large set of putative antiviral RNAi factors.
Genetic requirements of antiviral RNAi in C. elegans
Our genetic analysis confirms earlier observations that antiviral
RNAi in C. elegans overlaps the canonical dsRNA-siRNA pathway
of RNAi [46–48]. For example, 35 known RNAi factors
participate in the worm antiviral RNAi against FHV (Table S1).
Antiviral RNAi against FHV is enhanced in both ergo-1 and drh-2
mutant worms that exhibit enhanced RNAi. Furthermore, this
work together with previous studies shows that (i) antiviral RNAi
induced by either FHV or VSV requires dcr-1, (ii) production of
both VSV and FHV siRNAs was dependent on rde-4 and (iii)
neither rde-1 nor drh-1 is essential for the biogenesis of viRNAs.
These findings revealed a role of RDE-4, most likely with DCR-1
in a previously identified complex, in the sensing of viral RNA
trigger and in the biogenesis of viRNAs. Whereas these data
support a shared biogenesis pathway for viRNAs, exo- and endo-
siRNAs in C. elegans [30], an indispensable role for rde-4 in the
viRNA biogenesis is distinct from D. melanogaster in which DCR-2
but not the rde-4 homolog (R2D2), is essential for viRNA
production [14].
Primary siRNAs processed directly from exogenous dsRNA are
not sufficient abundant to detect by Northern blot hybridizations
in rde-1 worms [35,43,58], in contrast to FHV viRNAs. This
difference is probably due to the robust supply of viral dsRNA
from active viral RNA replication in rde-1 worms whereas the
amount of exogenous dsRNA is limited in the absence of RDR-
dependent dsRNA synthesis. Furthermore, our feeding RNAi
screens indicate that a majority of the known exoRNAi factors
may not participate in the worm antiviral RNAi against FHV
(Table S1). In addition, whereas drh-1 is essential for antiviral
Figure 5. Genetic epistatic analysis of antiviral RNAi. (A, C, E) Accumulation of the FR1gfp replicon RNAs in single and double knockout worm
mutants 48 after replicon replication. (B) Accumulation of (-) viRNAs in single and double knockout worm mutants 48 after replicon replication as
described in Figure 2. A combination of 18
32P end-labeled DNA oligos corresponding to eGFP coding sequence in tandem was used as the probe for
viral siRNA detection. The same filters were probed for miR-238 after stripping. (D) unc-22 RNAi phenotype in response to unc-22 dsRNA
microinjected at 100 mg/ml as described in Figure 3.
doi:10.1371/journal.ppat.1000286.g005
Genetic Analysis of Antiviral RNAi in C. elegans
PLoS Pathogens | www.plospathogens.org 8 February 2009 | Volume 5 | Issue 2 | e1000286RNAi against FHV, it is dispensable for exoRNAi. These data
suggest that antiviral RNAi and exoRNAi pathways in C. elegans
are genetically distinct even though both are initiated by RDE-4
and DCR-1.
An increased inhibition of the worm antiviral RNAi against
FHV was observed in rde-1;C04F12.1 double mutant than in either
single mutant, indicating that FHV is targeted by two parallel
AGO-dependent antiviral RNAi pathways in C. elegans. This
conclusion is also supported by previously observations that
knockdown of either rde-1 or C04F12.1 individually enhances the
VSV accumulation [48] and that RNAi suppression by B2 further
increases FHV accumulation in rde-1 worms [46]. Both RDE-1
and C04F12.1 belong to the substantially expanded subfamily of
AGOs found only in worms and many members in this subfamily
have been shown to act either in parallel or sequentially in exo-
RNAi [41,42]. Thus, expansion of this AGO subfamily in C. elegans
may represent a unique strategy of host adaptation to viral
infection, distinct or in addition to the strategy used by insects in
which the evolution rate of antiviral RNAi factors DCR2 and
AGO2 is much faster than that of their miRNA pathway
counterparts DCR1 and AGO1 [61,62].
DRH-1 directs antiviral RNAi downstream of viRNA
biogenesis
Several lines of evidence illustrate that drh-1 has a specific, non-
redundant role in the rde-4-dependent antiviral RNAi pathway in C.
elegans. Either depletion of drh-1 mRNA by feeding RNAi or a
genetic lesion in drh-1 blocked antiviral RNAi against FR1gfp, an
FHV-based replicon that does not express VSR B2 and thus
exhibits aspecificdefecttosuppressantiviral RNAi.B2 isadsRNA/
siRNA-binding protein which is located both inside the viral
replication complex to inhibit the dicing of nascent dsRNA
replicative intermediates into viRNAs and in the cytoplasm to
inhibit the activity of viral siRNAs [13,23,46,63,64]. The antiviral
RNAi against FHV was inhibited in drh-1 worms as efficiently as in
rde-4 and rde-1 mutant worms. A time course analysis further
suggests that DRH-1, RDE-4 and RDE-1 may all participate in the
early induction of antiviral RNAi. Finally, epistatic analysis showed
that the FHVreplicon did not replicate to higher levels in rde-4:drh-1
double mutant than in either single mutant, demonstrating that drh-
1 specifically acts in the rde-4-initiated antiviral RNAi pathway.
Notably, inhibition of antiviral RNAi by the drh-1 mutant allele did
not prevent the production of viRNAs in either drh-1 single mutant
or rde-1:drh-1 double mutant worms, indicating that defects of drh-1
wormsinantiviralRNAiweresimilartorde-1mutantsbutdistinctto
rde-4 worms. These data together show that drh-1 of C. elegans acts
downstream of dcr-1 and rde-4 in the antiviral RNAi pathway and
does not play a critical role in the sensing of the viral RNA trigger.
C. elegans DRHs may regulate specificity of distinct siRNA
pathways
Previous knockdown experiments have established a genetic
requirement for the DRH family of genes in the canonical RNAi
[6,27]. Use of drh-3 mutant worms has further shown that DRH-3
mediates germline RNAi and endo-RNAi, but is dispensable for
somatic RNAi [27,57]. Our results show that neither drh-1 nor drh-
2 plays a role in the biogenesis of miRNAs, endo-siRNAs and
piRNAs and that drh-1 mutant worms supported RNAi in the
soma with only a negligibly reduced efficiency. Thus, drh-1 is
essential for antiviral RNAi but is largely dispensable for both
endo-RNAi and somatic RNAi. In contrast, drh-2 mutant worms
exhibited enhanced response to both somatic RNAi and antiviral
RNAi. Isolation of double drh knockout mutants, which is not
possible to achieve by genetic crosses between the single mutants
because of their close proximity, will be necessary to determine if
the observed somatic RNAi in drh-1 worms is mediated by drh-3
and/or drh-2.
Current models indicate that DRH-1/2 and DRH-3 participate
in the biogenesis of exo-and endo-siRNAs, respectively, in distinct
complexes with DCR-1 and that primary siRNAs thus generated
are loaded in a particular AGO to guide RDR-dependent
amplification of secondary siRNAs required for specific degrada-
tion of target mRNA [27,34,41,58,65]. Results presented in this
work indicate that DRH family proteins play an essential role in
siRNA pathways by acting downstream of the DCR-1/RDE-4-
dependent siRNA biogenesis to mediate both specific and
redundant siRNA pathways. Since in vivo interactions of DRH
proteins with DCR-1 and RDE-4 have been detected [6,27], we
propose that DRH protein facilitate the binding of primary
siRNAs to AGOs, the amplification of secondary siRNAs, or the
targeting and cleavages of the mRNA. The essential role of DRH-
3 and DRH-1 specifically in the endo-siRNA/germline exo-
siRNA and viRNA pathways, respectively, may be due to tissue
and cell-specific localization of DRH proteins and of dsRNA
trigger and mRNA targets. In contrast, somatic RNAi may be
mediated redundantly by DRH-1, possibly with DRH-3, which is
supported indirectly by the observation that although all of the
known endo-RNAi worm mutants are defective in the biogenesis
of endo-siRNAs, enhancement of somatic RNAi were detected in
rrf-3, eri-1 and ergo-1 mutants, but was not reported for drh-3
mutant worms. DRH-2 may compete with DRH-1 for binding to
the same or a similar set of co-factors, thereby inhibiting DRH-1-
dependent antiviral RNAi and somatic RNAi. This hypothesis is
consistent with our observation that the drh-2 mutant allele failed
to enhance antiviral RNAi against FHV in rde-1 and rde-4 mutant
worms that are defective in the drh-1-dependent viRNA pathway.
Conserved antiviral function of RLR members in C.
elegans and mammals
Our demonstration that the viral immunity is regulated by drh-1
and drh-2 in C. elegans indicates an evolutionarily conserved antiviral
role of the RLR family between worms and mammals. In mammals,
RLR members RIG-I and MDA5 are essential for controlling
infection of two distinct sets of ssRNA viruses. Current models
envision that recognition of specific viral RNA forms by the C-
terminal repressor domain activates a signaling cascade via two
caspase activation and recruitment domains (CARD) at the N-
terminus that culminates in the transcription of cytokine genes and
broad-spectrum immunity [1–3]. The third RLR member LGP2 is
analogous to DRH-2 since it shares homology with RIG-I and
M D A 5i nt h eh e l i c a s ea n dr e p r e s s o rd o m a i n sw i t h o u tt h eN - t e r m i n a l
CARD domains, and appears to repress RIG-I signaling but
contribute to MAD5 signaling [1–3]. Although the N-terminal
regions of DRH-1 and DRH-3 are highly homologous, neither
contains a CARD domain or is transcriptionally induced upon viral
replication. Our genetic analysis further suggests that drh-1 directs
antiviral RNAi downstream of both the sensing and the processing of
the viral RNA trigger into viRNAs. This may explain why DRH
proteins of C. elegans do not contain CARD domains, which mediate
downstream signaling events by protein-protein interactions in
mammals.
Methods
C. elegans genetics and culture
The Bristol strain N2 was used as the standard wild-type strain.
Alleles used in this study are all derived from N2 and include rde-
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1(tm1860),a n dC04F12.1(tm1637). The genotypes of rde-1 and rde-4
worms were confirmed using skn-1 feeding RNAi. The genotypes of
the rest worm strains containing single or double mutations were
confirmed by PCR and/or feeding RNAi targeting skn-1.
Transgene construct and transgenic worms
Transgene construct carrying FR1gfp replicon was a derivative
of pFR1-3 by replacing the NcoI-SacI fragment of FHV RNA1 by
the full length enhanced GFP coding region as described
previously [46,53]. This created a translational fusion of GFP
with the N-terminal 23 amino acids of B2 and deletion of
approximately 200 nucleotides from the B2 ORF. Animals were
made transgenic by gonadal microinjection following standard
protocol as described [46]. Briefly, FR1gfp plasmid (final
concentration 5 mg/ml) was mixed with the rol-6D plasmid
pRF4 (final concentration 100 mg/ml) for injection into wild-type
N2 animals. Generation of worm integrants carrying FR1gfp
transgene and assay for viral replication was carried out as
described previously [46].
RNAi experiments
Injection and feeding RNAi were carried out as previously
reported. Briefly, for unc-22 dsRNA preparation, unc-22 single-
stranded RNAs of both polarities were in vitro transcribed from a
cDNA fragment amplified using T7 promoter-tagged primer
unc22T7plus (TAATACGACTCACTATAGGAGTTGGGA-
GAGGATGAAGCT) and primer unc22T7minus (TAATAC-
GACTCACTATAGGCCACCGTTGTCACGTGGAGGA). For
injection RNAi, unc-22 dsRNA at 25 mg/ml or 100 mg/ml in water
was delivered into intestine of young adult worms through
microinjection. The injected worms were then transferred onto
fresh NGM plates 8 hours post microinjection. Progenies produced
between 8 and 32 hours post microinjection were scored for unc-22
phenotype. Feeding RNAi targeting skn-1 or dpy-13 was performed
by feeding worms on E. coli. HT115 strains that express dsRNA
corresponding to skn-1 and dpy-13, respectively. IPTG at final
concentration of 1 mM was used for the induction of dsRNA
expression. The P-value on the differences of unc-22 RNAi
phenotype (paralysis) between worm strains was calculated using
unpaired t test calculator (http://www.graphpad.com/quickcalcs/
ttest1.cfm?Format=SD).
RNA preparation and Northern analysis
Total RNA was prepared using the TRI Reagent method (MRC,
Inc.). Small RNAs were enriched using the mirVana kit (Ambion).
For high molecular viral RNA analysis, 3 to 6 mgt o t a lR N Ap e rl a n e
was fractionated in 1.2% agarose gel. For small RNA analysis, 30 to
50 mg of enriched small RNAs per lane was resolved using 15%
acrylamide denaturing gel along with chemically synthesized and
end-labeled siRNAs as size markers. After electrophoreses, the RNA
samples were transferred onto Hybond N+ membrane (Amersham
Biosciences) and UV crosslinked using 1.8610
5 mJ/CM
2 as output
power (SpectroLinker). For small RNA analysis, membranes were
hybridized with
32P-labeled oligo DNA probes in PerfectHyb buffer
(Sigma). For northern blot detection of drh-1 and drh-2 transcripts,
32P-labelled DNA probes were prepared using genomic DNA
fragments amplified by PCR. Primer tm1329_internal_b
(ATACTCTGCCTCGAGCCGAT) and primer Tm1329minus
(TCAGTCGTATCTCCAATTTTCGA) were used to amplify
genomic DNA as the drh-1 specific probe, while primer drh-
21780plus (AGTAGCATTCGTTCGAGAGTT) and primer
Ok951minus (TTGCTTTCCTGGACATGAAGTG) were used to
generate the drh-2 specific probe. Sequences for oligo probes used for
the detection of endogenous small RNAs were: miR-238,
CTGAATGGCATCGGAGTACAAA; miR-58, ATTGCCGTA-
CTGAACGATCTCA; miR-2, GCACATCAAAGCTGGCTGT-
GATA; lin-4, TCACACTTGAGGTCTCAGGGA; Let-7, AAC-
TATACAACCTACTACCTCA; X-cluster siRNA, CGCGTATC-
TATTCAATTGAAT; K02E2.6 siRNA, ATCAGTTACTTGC-
CAATTTC; and 21U-1, CACGGTTAACGTACGTACCA
drh-1 and drh-2 functional rescue experiments
Transgenic lines in either drh-1(tm1329) or drh-2(ok951)
background that carried an extrachromosomal array correspond-
ing to WRW0640F2 were produced with microinjection, and were
crossed respectively with drh-1(tm1329) and drh-2(ok951) animals
homozygous for FR1gfp transgene. The F1 progenies in either drh-
1(tm1329) or drh-2(ok951) background were then examined for
GFP expression after being maintained at 20uC( drh-1)o r2 5 uC
(drh-2) for 36 hours after induction of the FR1gfp replicon
replication. The complete loss or significant reduction of green
fluorescence in F1 progenies that carried both FR1gfp and the
WRW0640F2 extrachromosomal array, as compared to that in F1
animals that carried FR1gfp only, was considered as successful drh-
1 function rescue. Likewise, increased GFP expression in F1
progenies that carried FR1gfp transgene only as compared to F1
progenies that carried both FR1gfp transgene and a WRW0640F2
extrachromosomal array, was considered as evidence for the
restoration of drh-2 function.
Imaging microscopy
GFP fluorescence images were collected using a CANON G2
digital camera mounted on an Olympus IMT-2 microscope.
Supporting Information
Table S1 Putative antiviral RNAi factors identified by feeding
RNAi screens
Found at: doi:10.1371/journal.ppat.1000286.s001 (0.06 MB
DOC)
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